People · Operator
Named in public records as an officer, director or promoter · active 2006–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Esperance Pharmaceuticals, Inc | — | Biotechnology | Series A | $10.4M | $36.2M | 2006 |
Hector Alila at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hector Alila on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ross Barrett | 1 | 5 |
| Joseph Lovett | 1 | 4 |
| Chad Souvignier | 1 | 4 |
| Richard Babb | 1 | 2 |
| Peter Hoang | 1 | 2 |
| Sonia Deggs | 1 | 1 |
| Carola Leuschner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.